- Pharmacology
- Allergy, Immunology, and ENT
- Cardiology
- Emergency Medicine
- Endocrinology
- Adolescent Medicine
- Gastroenterology
- Infectious Diseases
- Neurology
- OB/GYN
- Practice Improvement
- Gynecology
- Respiratory
- Dermatology
- Mental, Behavioral and Development Health
- Oncology
- Rheumatology
- Sexual Health
- Pain
FDA update: Rotavirus vaccine is not for infants with severe combined immunodeficiency disease
The US Food and Drug Administration has ordered a safety labeling change for RotaTeq oral solution.
The US Food and Drug Administration (FDA) has ordered a safety labeling change for RotaTeq (live pentavalent rotavirus vaccine) oral solution.
Adverse gastrointestinal reactions including gastroenteritis with severe diarrhea and prolonged shedding of vaccine virus have been reported in infants who received the vaccine and later were identified as having severe combined immunodeficiency disease (SCID).
RotaTeq oral vaccine is indicated for the prevention of gastroenteritis in infants and children caused by rotavirus serotypes G1, G2, G3, G4, and P1. It is administered in a 3-dose series to infants between 6 and 32 weeks of age.
The benefits of concurrent fetal and maternal heart rate monitoring
April 17th 2024A recent study revealed that employing maternal heart rate monitoring alongside fetal heart rate monitoring during labor significantly decreases the incidence of neonatal encephalopathy and severe neonatal acidemia.
Stress ulcer prophylaxis does not provide prevention of gastrointestinal bleeding in neonates
December 4th 2023In a poster abstract presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition held in Anaheim, California, stress ulcer prophylaxis (SUP) did not appear to provide benefit for prevention of gastrointestinal bleeding and did not increase SUP-associated adverse effects.
Hematocrit levels in newborns: EPP vs DCC study reveals surprising findings
November 15th 2023A recent study in JAMA Network Open investigates the impact of extrauterine placental perfusion versus delayed cord clamping on hematocrit levels in newborns, shedding light on potential alternatives for optimizing infant outcomes during birth.
